WeTrials
Recruiting

Phase III Trial of Observation Versus Irradiation for a Gross Totally Resected Grade II Meningioma

What is this study?

This study is comparing two different approaches for patients who have had a slow-growing brain tumor called a grade II meningioma completely removed by surgery. Researchers want to see if getting radiation therapy helps prevent the tumor from returning better than simply watching and monitoring the patient closely.

Who can participate?

You may be able to join if you have a single grade II meningioma that was completely removed by surgery within the last six months. Participants must not have had other recent cancers or previous radiation therapy to the head.

What will happen?

Depending on which group you are placed in, you will either receive regular close monitoring with brain scans or undergo targeted radiation therapy. Throughout the study, you will also provide blood or tissue samples, answer health questionnaires, and have regular check-ups.

Where and when?

This study is currently recruiting patients at various medical centers, including locations in Alabama and Arizona. Your care team can help you find the most convenient location.

Key Points
  • 1Compares radiation therapy against careful monitoring for brain tumor patients.
  • 2Only for patients whose tumor was completely removed by recent surgery.
  • 3Involves regular MRI scans, lab tests, and health questionnaires.

Related links

Outside pages about this study, checked by our team

Suggest a link
Conditions Studied
This study is investigating treatments for the following conditions
Grade 2 MeningiomaIntracranial Meningioma

This summary was generated using AI and may not capture all details. Always consult with a healthcare professional for medical advice.